A critical appraisal of the pharmacological management of stable angina

A critical appraisal of the pharmacological management of stable angina

The once dominant plaque-centric model of the pathophysiology and management of coronary artery disease (CAD) has long been questioned by a bulk of experimental and clinical evidence suggesting, among others, that coronary artery obstruction is not synonymous with myocardial ischaemia, ischaemia may...

Full description

Bibliographic Details
Main Authors:	Dimitrios Farmakis, Andrew Xanthopoulos, Filippos Triposkiadis
Format:	Article
Language:	English
Published:	Elsevier 2021-03-01
Series:	Hellenic Journal of Cardiology
Subjects:	chronic coronary artery disease stable angina angina pectoris beta blockers calcium channel blockers ranolazine
Online Access:	http://www.sciencedirect.com/science/article/pii/S1109966621000129

Similar Items

Ranolazine: Multifaceted role beyond coronary artery disease, a recent perspective
by: Gopal Chandra Ghosh, et al.
Published: (2018-01-01)

Angina in 2022: Current Perspectives
by: Roberto Manfredi, et al.
Published: (2022-11-01)

TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR
by: I. M. Sokolov
Published: (2016-01-01)

Update on evidence for treatment with ranolazine in stable angina
by: Federico Carbone, et al.
Published: (2013-10-01)

Physical activity and risk of all-cause mortality in patients with stable angina pectoris: Effect modification by β-blocker treatment
by: Indu Dhar, et al.
Published: (2022-12-01)

Extended-release ranolazine: critical evaluation of its use in stable angina
by: Melloni C, et al.
Published: (2011-08-01)

Real-World Data from the Use of Ranolazine in Patients with Stable Angina Pectoris: The RANGER Study
by: Christoforos Olympios, et al.
Published: (2024-03-01)

EL ESTUDIO INVEST DIEZ AÑOS DESPUÉS, TRÍO DE ASES PARA PEPINE / The INVEST Study after ten years; Three Aces for Pepine
by: Francisco L. Moreno-Martínez, et al.
Published: (2012-07-01)

Triple antianginal combinations in the treatment of elderly and senile patients with stable angina
by: S G Kanorskii, et al.
Published: (2016-12-01)

COMPARACIÓN DE ESTRATEGIAS TERAPÉUTICAS PARA EL CONTROL DE LA TENSIÓN ARTERIAL Y LA ANGINA DE PECHO EN PACIENTES CON HIPERTENSIÓN ARTERIAL Y CARDIOPATÍA ISQUÉMICA CRÓNICA EN LA PROVINCIA DE VILLA CLARA. APÉNDICE DEL ESTUDIO INVEST / Comparison of therapeutic strategies for the control of blood pressure and angina in patients with hypertension and chronic ischemic heart disease in the province of Villa Clara. Appendix of INVEST study
by: Omaida J. López Bernal, et al.
Published: (2011-06-01)

THERAPY OF STABLE ANGINA OF EFFORT BY TRIPLE COMBINATIONS OF ANTIANGINAL DRUGS IN GERIATRIC PRACTICE
by: S. G. Kanorsky, et al.
Published: (2017-11-01)

Epicardial Fat Thickness as a Diagnostic Marker of Coronary Lesions in Stable Angina Pectoris Patients
by: Ulzim Fajar
Published: (2021-03-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Current Evidence on Long-Term Prognostic Factors in Vasospastic Angina
by: Hack-Lyoung Kim, et al.
Published: (2021-09-01)

PERCUTANEOUS INTERVENTION IN STABLE ANGINA: WHAT ISSUES DO WE SOLVE?
by: Yu. A. Karpov, et al.
Published: (2018-04-01)

ORIGINAL PAPER <br>Dynamics of changes of the BNP concentration in patients with stable angina pectoris qualified for PTCA. Dependence on the selected morphological and haemodynamic parameters
by: Robert Irzmański, et al.
Published: (2006-03-01)

Effect of Opium Addiction on Aspirin Resistance in Stable Angina Pectoris
by: Afsaneh Forood, et al.
Published: (2014-01-01)

Place of the novel drug ranolazine in the treatment of coronary artery disease
by: GA Baryshnikova, et al.
Published: (2014-12-01)

A case of vasospastic angina. Vasospasm physiopathology: a new therapeutic role for ranolazine?
by: Carlo Uran, et al.
Published: (2020-08-01)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)
by: S. В. Fitilev, et al.
Published: (2018-05-01)

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND CALCIUM CHANNEL BLOCKERS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE ASSOCIATED WITH STABLE ANGINA AND ARTERIAL HYPERTENSION
by: Paplauskaya E. E.
Published: (2020-05-01)

Ivabradinum supplements the clinical efficacy of percutaneous coronary intervention in patients with coronary heart disease with stable angina
by: D. M Aronov, et al.
Published: (2017-06-01)

Tortuous diagnosis and treatment of a patient with coronary vasospastic angina(VSA)
by: Yan-Ying Yao, et al.
Published: (2023-03-01)

Chemical and pharmacological evaluation of the effectiveness of enalapril maleate in exertional angina pectoris in elderly and senile patients
by: I. M. Belay, et al.
Published: (2013-06-01)

Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French Cardiologists
by: Christophe Bauters, et al.
Published: (2015-11-01)

Refractory Coronary Vasospasm After Spine Surgery; A Rare Case Report
by: Ghazaleh Salehabadi, et al.
Published: (2023-01-01)

Predictors of Long-Term Mortality in Patients with Stable Angina Pectoris and Coronary Slow Flow
by: Sukru Aksoy, et al.
Published: (2023-04-01)

MULTISLICE COMPUTED TOMOGRAPHY CORONARY ANGIOGRAPHY IN PATIENTS WITH ANGINA PECTORIS
by: D. Ilić, et al.
Published: (2016-04-01)

Risk Factors of Plaque Progression in Patients with Angina Pectoris and Their Relationships with Coronary CT Angiography
by: Najun ZHU, et al.
Published: (2023-03-01)

A New Biomarker in The Distinction Between Stable Coronary Artery Disease and Acute Coronary Syndrome:Thiols
by: Fatih Balcı, et al.
Published: (2022-07-01)

Relation of IL-1?, IL-5, IL-6 and IL-8 with stable angina pectoris
by: Hamza A. Khalid, et al.
Published: (2023-04-01)

Remarks on Angina Pectoris
by: Sabino Scardi, et al.
Published: (2005-03-01)

Is serum fibroblast growth factor 21 associated with the severity or presence of coronary artery disease?
by: Nar Gokay, et al.
Published: (2022-01-01)

Plasma α1-antitrypsin: A Neglected Predictor of Angiographic Severity in Patients with Stable Angina Pectoris
by: Hui Zhao, et al.
Published: (2015-01-01)

Cardiac shock-wave therapy in the treatment of coronary artery disease: systematic review and meta-analysis
by: Greta Burneikaitė, et al.
Published: (2017-04-01)

Angina de Prinzmetal Angina de Prinzmetal Prinzmetal's angina
by: Eduardo Contreras Zuniga, et al.
Published: (2009-08-01)

Manejo farmacológico de la angina
by: Jorge Jalil Milad
Published: (2017-03-01)

Comparison of the safety and efficacy of ivabradine and nebivolol mono- and combination therapies in the treatment of stable angina pectoris patients with left ventricular dysfunction
by: Rasim Kutlu, et al.
Published: (2013-06-01)

On-Pump Beating/Non-Beating CABG in Stable Angina Have Similar Outcomes
by: Victor Dayan, et al.

Pharmacological protection of the myocardium with reamberin in coronary artery bypass grafting in patients with postinfarction angina
by: Georgiy Ivanovich Sidorenko, et al.
Published: (2011-09-01)